Form 8-K - Current report:
SEC Accession No. 0001193125-22-058164
Filing Date
2022-02-28
Accepted
2022-02-28 16:56:16
Documents
14
Period of Report
2022-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d287154d8k.htm   iXBRL 8-K 24968
2 EX-99.1 d287154dex991.htm EX-99.1 81501
6 GRAPHIC g287154dsp00001.jpg GRAPHIC 3718
  Complete submission text file 0001193125-22-058164.txt   244233

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arvn-20220228.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20220228_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20220228_pre.xml EX-101.PRE 11262
8 EXTRACTED XBRL INSTANCE DOCUMENT d287154d8k_htm.xml XML 3348
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 22690836
SIC: 2834 Pharmaceutical Preparations